Mari Muldmaa
- Neurology top 10%
- Parkinson's Disease Mechanisms and Treatments 4
- Neurological disorders and treatments 2
- Amyotrophic Lateral Sclerosis Research 1
- Neurological diseases and metabolism 1
-
- Parkinson's Disease Mechanisms and Treatments 4
- Neurological disorders and treatments 2
- Amyotrophic Lateral Sclerosis Research 1
- Neurological diseases and metabolism 1
-
- Hormonal and reproductive studies 1
-
- Adenosine and Purinergic Signaling 1
-
- Obsessive-Compulsive Spectrum Disorders 1
-
- Cancer Mechanisms and Therapy 1
Mari Muldmaa
8 papers receiving 170 citations
Peers
Comparison fields: 5 of 48
- Neurology 121
- Physical Therapy, Sports Therapy and Rehabilitation 24
- Neurology 12
- Psychiatry and Mental health 22
- Cognitive Neuroscience 23
Countries citing papers authored by Mari Muldmaa
This map shows the geographic impact of Mari Muldmaa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mari Muldmaa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mari Muldmaa more than expected).
Fields of papers citing papers by Mari Muldmaa
This network shows the impact of papers produced by Mari Muldmaa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mari Muldmaa. The network helps show where Mari Muldmaa may publish in the future.
Co-authorship network
The 24 scholars most cited alongside Mari Muldmaa, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2024 | 2 | |
| 3 | 2020 | 4 | |
| 4 | 2019 | 6 | |
| 5 | 2016 | 29 | |
| 6 | 2015 | 101 | |
| 7 | Methcathinone (ephedrone) and manganese both reduce D2-receptor function: An animal SPECT study | 2012 | 2 |
| 8 | 2010 | 25 |
About Mari Muldmaa
Mari Muldmaa is a scholar working on Neurology, Toxicology and Physical Therapy, Sports Therapy and Rehabilitation, having authored 8 papers that have together received 170 indexed citations. Recurring topics across this work include Parkinson's Disease Mechanisms and Treatments (4 papers), Neurological disorders and treatments (2 papers), Hormonal and reproductive studies (1 paper), Amyotrophic Lateral Sclerosis Research (1 paper), Adenosine and Purinergic Signaling (1 paper), Obsessive-Compulsive Spectrum Disorders (1 paper), Neurological diseases and metabolism (1 paper) and Cancer Mechanisms and Therapy (1 paper). The work is most often cited by research in Neurology (121 citations), Physical Therapy, Sports Therapy and Rehabilitation (24 citations) and Neurology (12 citations). Mari Muldmaa has collaborated with scholars based in Estonia, Australia and United Kingdom. Frequent co-authors include Liis Kadastik‐Eerme, Pille Taba, Nele Taba, Sulev Kõks, Eero Vasar, Vallo Tillmann, John Hardy, Alan Pittman, Niccolò E. Mencacci and Katrin Sikk. Their work appears in journals such as Parkinson s Disease, Journal of Neural Transmission, Health and Quality of Life Outcomes, Experimental and Clinical Endocrinology & Diabetes and Experimental Biology and Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.